Maintenance therapy and 3-year outcome of opioid-dependent prisoners: A prospective study in France (2003-06)

Addiction

Volumn 104, Issue 7, 2009, Pages 1233-1240

  Marzo, Jean Noël ^a,b   Rotily, Michel ^c   Meroueh, Fadi ^d   Varastet, Marina ^c   Hunault, Catherine ^c   Obradovic, Ivana ^e   Zin, Adeline ^c  

^a Réseau d'Etudes sur les Conduites Addictives   (France)

^b Sciences et Société   (France)

^c ClinSearch   (France)

^d UCSA de Villeneuve lès Maguelone   (France)

^e Observatoire Français des Drogues et des Toxicomanies OFDT   (France)

Author keywords

Buprenorphine; Cohort study; Methadone; Opioid addiction; Prison

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUPRENORPHINE; COCAINE; DIAMORPHINE; HYPNOTIC AGENT; KETAMINE; METHADONE; NEUROLEPTIC AGENT; OPIATE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; COMORBIDITY; DRUG DEPENDENCE; FEMALE; FRANCE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCRIPTION; PRISONER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BUPRENORPHINE; FEMALE; FRANCE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; PRISONERS; PRISONS; PROSPECTIVE STUDIES; RECURRENCE; YOUNG ADULT;

EID: 66749146110     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02558.x     Document Type: Article

References (26)

1. World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC), United Nations Joint Programme on HIV/AIDS (UNAIDS). Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention: Position Paper. Geneva : WHO 2004.
2. Gossop M., Marsden J., Stewart D., Kidd T. The National Treatment Outcome Research Study (NTORS): 4-5-year follow-up results. Addiction 2003 98 : 291 303. (Pubitemid 36269568)
3. Teesson M., Mills K., Ross J., Darke S., Williamson A., Havard A. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008 103 : 80 8.
4. Werb D., Kerr T., Marsh D., Li K., Montaner J., Wood E. Effect of methadone treatment on incarceration rates among injection drug users. Eur Addict Res 2008 14 : 143 9.
5. Durand E. Changes in high-dose buprenorphine maintenance therapy at the Fleury-Merogis (France) prison since 1996 Ann Med Interne (Paris) 2001 152 : 9 14.
6. Michel L., Maguet O. Guidelines for substitution treatments in prison populations Encephale 2005 31 : 92 7.
7. Turnbull P., McSweeney T. Drug treatments in prison and aftercare: a literature review and results of a survey of European countries. In : Pompidou Group, editors. Drug Misusing Offenders in Prison and After Release. Strasbourg : Council of Europe Publishing 2000, p. 41 59.
8. Springer S. A., Bruce R. D. A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners. J Opioid Manag 2008 4 : 81 6.
9. Fazel S., Bains P., Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006 101 : 181 91.
10. Bird S. M., Hutchinson S. J. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction 2003 98 : 185 90.
11. Verger P., Rotily M., Prudhomme J., Bird S. High mortality rates among inmates during the year following their discharge from a French prison. J Forensic Sci 2003 48 : 614 6.
12. Seaman S. R., Brettle R. P., Gore S. M. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ 1998 316 : 426 8.
13. Seymour A., Oliver J. S., Black M. Drug-related deaths among recently released prisoners in the Strathclyde region of Scotland. J Forensic Sci 2000 45 : 649 54.
14. Farrell M., Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008 103 : 251 5.
15. Dolan K., Hall W., Wodak A. Methadone maintenance reduces injecting in prison. BMJ 1996 312 : 1162. (Pubitemid 26131313)
16. Dolan K. A., Wodak A. D., Hall W. D. Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev 1998 17 : 153 8.
17. Dolan K. A., Shearer J., White B., Zhou J., Kaldor J., Wodak A. D. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction 2005 100 : 820 8.
18. Heimer R., Catania H., Newman R. G., Zambrano J., Brunet A., Ortiz A. M. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico. Drug Alcohol Depend 2006 83 : 122 9.
19. Rotily M., Delorme C., Galinier A., Escaffre N., Moatti J. P. HIV risk behavior in prison and factors associated with reincarceration of injection drug users Presse Med 2000 29 : 1549 56.
20. Kinlock T. W., Gordon M. S., Schwartz R. P., O'Grady K. E. A. Study of methadone maintenance for male prisoners: 3-month postrelease outcomes. Crim Justice Behav 2008 35 : 34 47.
21. Gordon M. S., Kinlock T. W., Schwartz R. P., O'Grady K. E. A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release. Addiction 2008 103 : 1333 42.
22. McLellan A. T., Luborsky L., Woody G. E., O'Brien C. P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980 168 : 26 33. (Pubitemid 10187569)
23. Cadet-Taïrou A., Costes J. M., Bello P. Y., Palle C. How many opiate users are there on HDB. Trends 2004 37 : 1 4. Available at: http://www.ofdt.fr/BDD/publications/docs/eftaack6.pdf (accessed 20 April 2009)
24. Levasseur L., Marzo J. N., Ross N., Blatier C. Frequencyof re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis Ann Med Interne (Paris) 2002 153 : 1S14 19.
25. Michel L., Lang J. P. Benzodiazepines and forensic aspects Encephale 2003 29 : 479 85.
26. Gillet C., Polard E., Mauduit N., Allain H. Acting out and psychoactive substances: alcohol, drugs, illicit substances Encephale 2001 27 : 351 9.